ALIF SARAH: Open Payments
NPI 1992866651 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 50 payments from 14 companies in 2025. Trend: 2023 $1,069 · 2024 $1,020 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $303 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $222 |
| ABBVIE INC. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| PFIZER INC. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Exact Sciences Corporation | 2 | $32 |
| Eisai Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Kerendia, AIRSUPRA, VRAYLAR, REXULTI, LEQVIO, ELIQUIS, FARXIGA, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
